A model for experimentally induced temperomandibular joint arthritis in rats: Effects of carrageenan on neuropeptide-like immunoreactivity

Neuropeptides

Volumn 30, Issue 1, 1996, Pages 37-41

  Lundeberg, T ^a,b,c   Alstergren, P ^a   Appelgren, A ^a   Appelgren, B ^a   Carleson, J ^a   Kopp, S ^a   Theodorsson, E ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Division of Physiology II   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CARRAGEENAN; NEUROKININ A; NEUROPEPTIDE Y; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; HORMONE BLOOD LEVEL; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPOROMANDIBULAR JOINT;

EID: 0029919751     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90052-9     Document Type: Article

References (32)

1. Holsapple, M. P. and Yim, G. K. W. Therapeutic reduction of ongoing carrageenin-induced inflammation by lipoxygenase, but not cylooxygenase inhibitors. Inflammation 1984; 3: 223-230.
2. Neil, A., Benoist, J. M., Kayser, V. and Guilbaud, G. Initial nociceptive sensitization in carrageenin-induced rat paw inflammation is dependent on amine autacoid mechanisms: electrophysiological and behavioural evidence obtained with a quaternary antihistamine, thiazinamium. Exp. Brain Res. 1987; 65: 343-351.
3. Di Rosa, M., Giroud, J. P. and Willoughby, D. A. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol. 1971; 104: 15-29.
4. Carmichael, D. J., Gillard, G. C., Lowther, D. A., Handley, C. J. and Santer, V. B. Carrageenin-induced arthritis. IV. Rate changes matrix proteoglycansynthesis. Arthritis Rheum. 1977; 20: 834-840.
5. Gillard, G. O. and Lowther, D. A. Carrageenin-induced arthritis. II. Effects of intra-articular injection of carrageenin on the synthesis of proteoglycan in articular cartilage. Arthritis Rheum. 1976; 19: 918-922.
6. Alstergren, P., Appelgren, A., Appelgren, B., Kopp, S., Lundeberg, T. and Theodorsson, E. Determination of temporomandibular joint fluid concentrations using vitamin B12 as an internal standard. Eur. J. Oral. Sci. 1995; 103: 214-218.
7. Alstergren, P., Appelgren, A., Appelggen, B., Kopp, S., Kunderberg, T., Theodorsson, E. Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch. Oral. Biol. (in press).
8. Appelgren, A., Appelgren, B. and Eriksson, S. Neuropeptides in temporomandibular joints with rheumatoid arthritis. A clinical study. Scand. J. Dent. Res. 1991; 99: 5, 19-21.
9. Appelgren, A., Appelgren, B., Kopp, S., Lundeberg, T. and Theodorsson, E. Relation between the intra-articular temperature of the temporomandibular joint and the presence of neuropeptide Y-like immunoreactivity in the joint fluid. Acta Odontol. Scand. 1993; 51: 1-8.
10. Appelgren, A., Appelgren, B., Kopp, S., Lundeberg, T. and Theodorsson, E. Relation between intra-articular temperature of the arthritic temporomandibular joint and presence of calcitonin gene-related peptide in the joint fluid. A clinical study. Acta Odontol. Scand. 1993; 51: 285-291.
11. Alstergren, P., Appelgren, A., Appelgren, B., Kopp, S., Lundeberg, T. and Theodorsson, E. Intraarticular glucocorticoid treatment of temporomandibular joint arthritis with consideration to effects on joint fluid content of neuropeptide Y. Acta. Odontol. Scand. (in press).
12. Theodorsson-Norheim, E., Hemsen, A., Brodin, E. and Lundberg, J. M. Sample handling techniques when analyzing regulatory peptides. Life Sci. 1987; 41: 845-848.
13. Brodin, E., Lindefors, N., Dalsgaard, C. J. Theodorsson-Northeim, E. and Rosell, S. Tachykinin multiplicity in the rat central nervous system as studied using antisera against substance P and neurokinin A. Regul. Pept. 1986; 13: 253-272.
14. Theodorsson-Norheim, E., Brodin, E., Norheim, I. and Rosell, S. Antisera raised against eledoisin and kassinin detect immunoreactive material in rat tissue extracts: tissue distribution and Chromatographic characterization. Regul. Pept. 1984; 9: 229-244.
15. Theodorsson-Norheim, E., Hemsen, A. and Lundberg, J. M. Radioimmunoassay for neuropeptide Y(NPY): Chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand. J. Clin. Lab. Invest 1985; 45: 355-365.
16. Theodorsson-Norheim, E., Norheim I., Öberg, K. et al. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients. Biochem. Biophys. Res. Commun. 1985; 131: 77-83.
17. Gamse, R., Posch, M., Saria A. and Jancso, G. Several mediators appear to interact in neurogenic inflammation. Acta. Physiol. Hung. 1987; 69: 343-354.
18. Beck, P. W. and Handwerker, H. O. Bradykinin and serotonin effects on various types of cutaneous nerve fibers. Pflugers Arch. 1974; 347: 209-222.
19. Chahl, L. A. and Iggo, A. The effects of bradykinin and prostaglandin E, on rat cutaneous afferent nerve activity. Br. J. Pharmacol. 1977; 59: 343-347.
20. Lam, F. and Ferrell, W. R. Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann. Rheum. Dis. 1989; 48: 928-932.
21. Birch, P. J., Harrison, S. M., Hayex, A. G., Rogers, H. and Tyers, M. B. The non-peptide NK, receptor antagonist, (+)-CP-96, 345, produces antinociceptive and antioedema effects in the rat. Br. J. Pharmacol 1992; 105: 508-510.
22. Hope, P. J., Jarrot, B., Schaible, H. G., Clarke, R. W. and Duggan, A. W. Release and spread of immunoreactive neurokinin A in the cat spinal cord in a model of acute arthritis. Brain Res. 1990; 553: 292-299.
23. Schaible, H. G., Jarrott, B., Hope, P. J. and Duggan, A. W. Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res. 1990; 529: 214-223.
24. Woolf, C. J. and Wiesenfeld-Hallin, Z. Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociception reflex in the rat. Neurosci. Lett. 1986; 66: 226-230.
25. Satoh, M., Kuraishi, Y. and Kawamura, M. Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress induced hyperalgesia: comparison with carragenan-induced hyperalgesia. Pain 1992; 49: 273-278.
26. Gamse, R., Mroz, E., Leeman, S. and Lembeck, F. The intestine as source of immunoreactive substance P in plasma of the cat. Naunyn-Schiedeberg's Arch. Pharmacol. 1978; 305: 17-21.
27. Wimalawansa, S. J. and Macintyre, I. Heterogeneity of plasma calcitonin gene-related peptide: partial characterisation of immunoreactive forms. Peptides 1988; 9: 407-410.
28. Ekblad, E., Edvinsson, L., Wahlstedt, C., Uddman, R., Håkansson, R. and Sundler, F. Neuropeptides Y co-exists and co-operate with noradrenaline in perivascular nerve fibers. Regul. Pept. 1984; 8: 225-235.
29. Morris, M., Kapoor, V. and Chalmers, J. Plasma neuropeptide Y concentration is increased after hemorrhage in conscious rats: relative contributions of sympathetic nerves and the adrenal medulla. J. Cardiovasc. Dis. 1987; 9: 541-545.
30. Erdös, E. G. and Skidgel R. A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989; 3: 145-151.
31. Nadel, J. A. Neural endopeptidase modulates neurogenic inflammation. Eur. Respir. J. 1991; 4: 745-754.
32. Wimalawansa, S. J. Effects of in vivo stimulation on molecular forms of circulatory calcitonin and calcitonin gene-related peptide in man. Mol. Cell. Endocrinol. 1990; 71: 13-29.